Article Details
Retrieved on: 2018-03-12 21:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors increased Aerie Pharmaceuticals Com (AERI) stake by 119.4% reported in 2017Q3 SEC filing. <b>Benchmark Capital</b> Advisors acquired 16,000 shares as Aerie Pharmaceuticals Com (AERI)'s stock declined 8.47%. The <b>Benchmark Capital</b> Advisors holds 29,400 shares with ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here